Unraveling the Causal Links Between Immune Cells, Lipids, and Cardiovascular Diseases: Insights from Mendelian Randomization
By: Fengwei He, Tian Yang, Wentao Zhang, Ming Liu and Hao Wu
References
- Varghese TP. Genetic markers of cardiovascular disease. Curr Probl Cardiol, 2024;49(7):
102588 . DOI: 10.1016/j.cpcardiol.2024.102588 - Blinnikova K, Cohen CW, McKeag ID. Lifestyle intervention for the prevention of cardiovascular disease. Prim Care. 2024;51(1):13–26. DOI: 10.1016/j.pop.2023.07.001
- Riksen NP, et al. Trained immunity in atherosclerotic cardiovascular disease. Nat Rev Cardiol, 2023;20(12):799–811. DOI: 10.1038/s41569-023-00894-y
- Zuo W, et al. Macrophage-driven cardiac inflammation and healing: Insights from homeostasis and myocardial infarction. Cell Mol Biol Lett. 2023;28(1):
81 . DOI: 10.1186/s11658-023-00491-4 - Ekroos K, et al. Lipid-based biomarkers for CVD, COPD, and aging - A translational perspective. Prog Lipid Res. 2020;78:
101030 . DOI: 10.1016/j.plipres.2020.101030 - Glavinovic T, et al. Physiological bases for the superiority of apolipoprotein b over low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol as a marker of cardiovascular risk. J Am Heart Assoc. 2022;11(20):p.
e025858 . DOI: 10.1161/JAHA.122.025858 - Aronova A, et al. Innate immune pathways in atherosclerosis-from signaling to long-term epigenetic reprogramming. Cells. 2023;12(19). DOI: 10.3390/cells12192359
- Sanderson E, et al. Mendelian randomization. Nat Rev Methods Primers. 2022;2:
a6 . DOI: 10.1038/s43586-021-00092-5 - Birney E. Mendelian Randomization. Cold Spring Harb Perspect Med. 2022;12(4):
a041302 . DOI: 10.1101/cshperspect.a041302 - Fleetwood AJ, et al. Immunometabolism in atherosclerotic disorders. Nat Cardiovasc Res. 2024;3(6):637–650. DOI: 10.1038/s44161-024-00473-5
- Bahrar H, et al. Innate immune memory in cardiometabolic disease. Cardiovasc Res. 2024;119(18):2774–2786. DOI: 10.1093/cvr/cvad030
- Henein MY, et al. The role of inflammation in cardiovascular disease. Int. J. Mol. Sci. 2022;23(21):
12906 . DOI: 10.3390/ijms232112906 - Jebari-Benslaiman S, et al. Pathophysiology of atherosclerosis. Int J Mol Sci. 2022;23(6):
3346 . DOI: 10.3390/ijms23063346 - Bonacina F, et al. Adoptive transfer of CX3CR1 transduced-T regulatory cells improves homing to the atherosclerotic plaques and dampens atherosclerosis progression. Cardiovasc Res. 2021;117(9):2069–2082. DOI: 10.1093/cvr/cvaa264
- Roy-Chowdhury E, et al. Human CD16+ monocytes promote a pro-atherosclerotic endothelial cell phenotype via CX3CR1-CX3CL1 interaction. Cardiovasc Res. 2021;117(6):1510–1522. DOI: 10.1093/cvr/cvaa234
- Bednar KJ, Lee JH, Ort T. Tregs in autoimmunity: Insights into intrinsic brake mechanism driving pathogenesis and immune homeostasis. Front Immunol. 2022;13:
932485 . DOI: 10.3389/fimmu.2022.932485 - Albany CJ, et al. Getting to the heart of the matter: The role of regulatory T-Cells (Tregs) in Cardiovascular Disease (CVD) and Atherosclerosis. Front Immunol. 2019;10:
2795 . DOI: 10.3389/fimmu.2019.02795 - Ceeraz S, et al. Harnessing CD8(+)CD28(-) regulatory T Cells as a tool to treat autoimmune disease. Cells. 2021;10(11):
2973 . DOI: 10.3390/cells10112973 - Ahmed A, et al. BCG revaccination in adults enhances pro-inflammatory markers of trained immunity along with anti-inflammatory pathways. iScience. 2023;26(10):
107889 . DOI: 10.1016/j.isci.2023.107889 - Bourbon E, et al. HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma. Blood Adv. 2023;7(5):744–755. DOI: 10.1182/bloodadvances.2021006563
- Kuan R, Agrawal DK, Thankam FG. Treg cells in atherosclerosis. Mol Biol Rep. 2021;48(5):4897–4910. DOI: 10.1007/s11033-021-06483-x
- Ou XM, et al. Treg immunomodulation contributes to the anti-atherosclerotic effects of huxin formula in ApoE(-/-) mice. Chin J Integr Med. 2024;30(10):896–905. DOI: 10.1007/s11655-024-3663-2
- Depuydt M, et al. Microanatomy of the human atherosclerotic plaque by single-cell transcriptomics. Circ Res. 2020;127(11):1437–1455. DOI: 10.1161/CIRCRESAHA.120.316770
- Ge P, et al. Single-cell atlas reveals different immune environments between stable and vulnerable atherosclerotic plaques. Front Immunol. 2022;13:
1085468 . DOI: 10.3389/fimmu.2022.1085468 - Kamtchum-Tatuene J, et al. Interleukin-6 predicts carotid plaque severity, vulnerability, and progression. Circ Res. 2022;131(2):e22–e33. DOI: 10.1161/CIRCRESAHA.122.320877
- Wang J, et al. Identification of immune cell infiltration and diagnostic biomarkers in unstable atherosclerotic plaques by integrated bioinformatics analysis and machine learning. Front Immunol. 2022;13:
956078 . DOI: 10.3389/fimmu.2022.956078 - Huang KK, et al. Identification of hub genes and their correlation with immune infiltration in coronary artery disease through bioinformatics and machine learning methods. J Thorac Dis. 2022;14(7):2621–2634. DOI: 10.21037/jtd-22-632
- Peet C, et al. Cardiac monocytes and macrophages after myocardial infarction. Cardiovasc Res. 2020;116(6):1101–1112. DOI: 10.1093/cvr/cvz336
- Dong Z, et al. Myocardial infarction drives trained immunity of monocytes, accelerating atherosclerosis. Eur Heart J. 2024;45(9):669–684. DOI: 10.1093/eurheartj/ehad787
- Zhang Q, et al. Signaling pathways and targeted therapy for myocardial infarction. Signal Transduct Target Ther. 2022;7(1):
78 . DOI: 10.1038/s41392-022-00925-z - Rizzo G, et al. Dynamics of monocyte-derived macrophage diversity in experimental myocardial infarction. Cardiovasc Res. 2023;119(3):772–785. DOI: 10.1093/cvr/cvac113
- Xie Z, et al. Identification and verification of biomarkers and immune infiltration in obesity-related atrial fibrillation. Biology (Basel). 2023;12(1):
121 . DOI: 10.3390/biology12010121 - Chu H, et al. Causal relationship between immune cells and atrial fibrillation: A Mendelian randomization study. Medicine (Baltimore). 2024;103(19):
e38079 . DOI: 10.1097/MD.0000000000038079 - Hulsmans M, et al. Recruited macrophages elicit atrial fibrillation. Science. 2023;381(6654):231–239. DOI: 10.1126/science.abq3061
- Zhou Y, et al. Association of inflammation indices with left atrial thrombus in patients with valvular atrial fibrillation. BMC Cardiovasc Disord. 2023;23(1):
9 . DOI: 10.1186/s12872-023-03036-x - Suehiro H, et al. Circulating intermediate monocytes and atrial structural remodeling associated with atrial fibrillation recurrence after catheter ablation. J Cardiovasc Electrophysiol. 2021;32(4):1035–1043. DOI: 10.1111/jce.14929
- Shaw P, et al. VEGF signaling: Role in angiogenesis and beyond. Biochim Biophys Acta Rev Cancer. 2024;1879(2):
189079 . DOI: 10.1016/j.bbcan.2024.189079 - Sun W, et al. Causal effects of immune cell surface antigens and functional outcome after ischemic stroke: a Mendelian randomization study. Front Immunol. 2024;15:
1353034 . DOI: 10.3389/fimmu.2024.1353034 - Zheng K, et al. Single-cell RNA-seq reveals the transcriptional landscape in ischemic stroke. J Cereb Blood Flow Metab. 2022;42(1):56–73. DOI: 10.1177/0271678X211026770
- Bai M, et al. Monocyte-related cytokines/chemokines in cerebral ischemic stroke. CNS Neurosci Ther, 2023;29(12):3693–3712. DOI: 10.1111/cns.14368
- Zheng Y, et al. T cell interactions with microglia in immune-inflammatory processes of ischemic stroke. Neural Regen Res. 2025;20(5):1277–1292. DOI: 10.4103/NRR.NRR-D-23-01385
- Wu S, et al. Updates of the role of B-cells in ischemic stroke. Front Cell Neurosci. 2024;18:
1340756 . DOI: 10.3389/fncel.2024.1340756 - Li Y, et al. Immunophenotyping schizophrenia subtypes stratified by antipsychotic response. Brain Behav Immun. 2024;123:656–671. DOI: 10.1016/j.bbi.2024.10.019
- Yu Y, et al. Immune-mediated diseases and risk of incident cardiovascular diseases: a prospective cohort study. Rheumatology (Oxford). 2024;63(3):706–714. DOI: 10.1093/rheumatology/kead266
- Kang H, Song J, Cheng Y. HDL regulates the risk of cardiometabolic and inflammatory-related diseases: Focusing on cholesterol efflux capacity. Int Immunopharmacol. 2024;138:
112622 . DOI: 10.1016/j.intimp.2024.112622 - Feingold KR. Introduction to lipids and lipoproteins. 2000.
- Das P, Ingole N. Lipoproteins and their effects on the cardiovascular system. Cureus. 2023;15(11):
e48865 . DOI: 10.7759/cureus.48865 - Liu C, et al. PCSK9 Inhibition: from current advances to evolving future. Cells, 2022;11(19). DOI: 10.3390/cells11192972
- Jain P. Traditional and novel non-statin lipid-lowering drugs. Indian Heart J. 2024;76(Suppl 1):S38–S43. DOI: 10.1016/j.ihj.2023.11.003
- Bottrich T, et al. Subpopulations of regulatory T cells are associated with subclinical atherosclerotic plaques, levels of LDL, and cardiorespiratory fitness in the elderly. J Sport Health Sci. 2024;13(3):288–296. DOI: 10.1016/j.jshs.2023.11.004
- Vallejo J, et al. Heterogeneity of immune cells in human atherosclerosis revealed by scRNA-Seq. Cardiovasc Res. 2021;117(13):2537–2543. DOI: 10.1093/cvr/cvab260
- McCaffrey TA, et al. RNAseq profiling of blood from patients with coronary artery disease: Signature of a T cell imbalance. J Mol Cell Cardiol Plus. 2023;4:
100033 . DOI: 10.1016/j.jmccpl.2023.100033 - Zhang H, Dhalla NS. The role of pro-inflammatory cytokines in the pathogenesis of cardiovascular disease. Int J Mol Sci. 2024;25(2):
1082 . DOI: 10.3390/ijms25021082 - Tabatabaei FS, et al. Endosomal Toll-Like Receptors intermediate negative impacts of viral diseases, autoimmune diseases, and inflammatory immune responses on the cardiovascular system. Expert Rev Clin Immunol. 2024;1–13. DOI: 10.1080/1744666X.2024.2392815
- Shah KS, et al. Clinical trial participation and COVID-19: a descriptive analysis from the American Heart Association’s Get With The Guidelines Registry. J Racial Ethn Health Disparities. 2023;10(2): 892–898. DOI: 10.1007/s40615-022-01277-8
- Hall EJ, et al. Longitudinal trends in cardiovascular risk factor profiles and complications among patients hospitalized for COVID-19 infection: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry. Circ Cardiovasc Qual Outcomes. 2023;16(5):
e009652 . DOI: 10.1161/CIRCOUTCOMES.122.009652
DOI: https://doi.org/10.5334/gh.1444 | Journal eISSN: 2211-8179
Language: English
Submitted on: Jan 22, 2025
Accepted on: Jun 16, 2025
Published on: Jul 3, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2025 Fengwei He, Tian Yang, Wentao Zhang, Ming Liu, Hao Wu, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.